CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 8-K Event Delisting notice · Other events
- 8-K Event Executive or director change · Other events
- 8-K Event Executive or director change
- RW Other RW
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- S-1 Offering Registration Statement
- 8-K Event Delisting notice · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Shareholder vote results
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy Corporate Controller bought 5,000 shares at $0.67 ($3,349)
- SC 13D/A Stake Beneficial Ownership Report
Page 14 of 25 · 494 filings